Prescription Drug Monitoring Programs

This page includes essential information and updates related to Prescription Monitoring Programs (PMPs) across the country. You can also stay up to date with the latest news and announcements, discover state PMP spotlights, and find helpful PMP resources including NASCSA’s 2024 Model PMP Act. For important updates directly from state administrators, use the contact form to sign up and stay informed.

State Controlled Substance and PMP Database

Prescription Drug Monitoring Programs (PDMP) / Prescription Monitoring Programs (PMP) are jurisdictionally operated electronic databases which, collect, maintain, and disseminate controlled substance prescription information specific to each jurisdiction’s laws and regulations. PDMP / PMPs are critical decision support tools that state officials, healthcare professionals, and law enforcement officers use to address prescription dug abuse, misuse, and diversion. PDMP and PMP are used interchangeably throughout this website as well as others.

Access state specific PMP information by clicking on any state or U.S. territory below. Available information includes PMP and controlled substance contact information, as well as PMP profiles. You may also access the data for all states in the table below. The database contains the most current information that is available to us.

PMP State Data Summary Table

State	Abbr	DATA FORMAT	Vendor	DISPENSE REPORT FREQUENCY	ZERO REPORT FREQUENCY	SCHEDULES	DRUGS OF CONCERN	IN-HOUSE ADMINISTRATED REPORTED	Vet Reporting	Prescriber Mandatory Use	Pharmacy Mandatory Use	STATE PMP WEBSITE	DISPENSER GUIDE LINK
Alabama	AL	4.2B	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	No	Yes	No	https://www.alabamapublichealth.gov/pdmp/	https://www.alabamapublichealth.gov/pdmp/assets/al-data-submission-dispenser-guide.pdf
Alaska	AK	4.1	Bamboo	DAILY	DAILY	C2-C4	NONE	No	No	Yes	No	https://www.commerce.alaska.gov/web/cbpl/ProfessionalLicensing/PrescriptionDrugMonitoringProgram.aspx	https://www.commerce.alaska.gov/web/Portals/5/pub/AK_Data_Submission_Dispenser_Guide_v3.0.pdf
Arizona	AZ	4.2B	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	Yes	https://pharmacypmp.az.gov/	https://drive.google.com/file/d/1R1wCymw9T5n2sqn8fQGuWeEoCChXmjB0/view?ts=67ca02cd
Arkansas	AR	4.2	Bamboo	DAILY	DAILY	C2-C5	NONE	No	Yes	Yes	No	https://healthy.arkansas.gov/programs-services/prevention-healthy-living/substance-misuse-injury-prevention/prescription-drug-monitoring-program/pdmp-for-healthcare-providers/	https://healthy.arkansas.gov/wp-content/uploads/AR-Data-Submission-Dispenser-Guide-5.28.25.pdf
California	CA	4.2B	Bamboo	WEEKLY	7 days/Weekly	C2-C5	NONE	No	Yes	Yes	Yes	https://oag.ca.gov/cures	https://pmpclearinghouse.zendesk.com/hc/en-us/article_attachments/31846119634451
Colorado	CO	4.2B	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://dpo.colorado.gov/PDMP	https://drive.google.com/file/d/0B-K5DhxXxJZbVnAyMkgzSVBwWUk/view?resourcekey=0-8cB79Dyf6hff7ThL-A-1og
Connecticut	CT	4.2A	Bamboo	DAILY	DAILY	C2-C5	Gabapentin, Naloxone, Insulin Drugs, Glucagon Drugs, Diabetes Devices, Diabetic Ketoacidosis devices	No	Yes	Yes	No	https://portal.ct.gov/dcp/prescription-monitoring-program/prescription-monitoring-program	https://portal.ct.gov/-/media/dcp/drug_control/pmp/educational-materials/ct-data-submission-dispenser-guide_v-24_april-2022.pdf
Delaware	DE	4.2	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	Yes	https://dpr.delaware.gov/boards/pmp/	https://go.bamboohealth.com/rs/228-ZPQ-393/images/DE-Data_SubmissionDispenserGuide_v2.2.pdf
Florida	FL	4.2B	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	Yes	www.e-forcse.com	https://www.floridahealth.gov/wp-content/uploads/2025/07/FLDataSubmissionDispenserGuide_ASAP4.2B_v4.030_final.pdf
Georgia	GA	4.2	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://dph.georgia.gov/pdmp	https://dph.georgia.gov/pdmp
Hawaii	HI	4.2	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://dcr.hawaii.gov/wp-content/uploads/2018/08/HAWAII-PDMP-FREQUENTLY-ASKED-QUESTIONS_updated-2018-FOR-WEB.pdf	https://law.hawaii.gov/wp-content/uploads/2024/05/HI-PDMP-Data-Submission-Dispenser-Guide_v3.0.pdf
Idaho	ID	4.2A	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://dopl.idaho.gov/bop/	https://dopl.idaho.gov/wp-content/uploads/2024/07/2024.04.ID-Data-Submission-Dispenser-Guide_v4.0_4.2-A.pdf
Illinois	IL	5	Logicoy	DAILY	DAILY	C2-C5	Gabapentin, Butalbital combinations, Muscle Relaxants (Cyclobenzaprine), Opioid Antagonists - using a class-based system rather than static product lists	No	No	Yes	No	https://www.ilpmp.org/CDC/login.php	https://rxsubmit-il.logicoy.com/PDMPSystemApp/guidebeforelogin#!#documents
Indiana	IN	4.2A	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	Yes	Yes	Yes - Remote Dispensing Facilities	www.in.gov/pla/inspect/	https://www.in.gov/pla/inspect/files/IN-PMP-Data-Submission-Dispenser-Guide_v-4.0-1.pdf
Iowa	IA	4.1	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://hhs.iowa.gov/public-health/data/health/substance-use/prescription-monitoring-program	https://dial.iowa.gov/media/7113/download?inline=
Kansas	KS	4.2B	Bamboo	DAILY	DAILY	C2-C4	Gabapentin, Promethazine with Codine, Any product with all three of the following: butalbital, acetaminophin, caffeine; Any compound with a detectable quantity of ephedreine; Any compound with a detectable quantity of pseudoephedrine	No	No	Yes	No	https://pharmacy.ks.gov/k-tracs	https://www.ktracs.ks.gov/home/showpublisheddocument/8480/638584628093930000
Kentucky	KY	4.2B	In-House	DAILY	Not Required	C2-C5	Gabapentin	Yes	No	Yes	Yes	https://www.chfs.ky.gov/agencies/os/oig/dai/deppb/Pages/kasper.aspx	https://ekasperupload.chfs.ky.gov/KASPER_Controlled_Substance_Reporting_Guide.pdf
Louisiana	LA	4.2B	Bamboo	DAILY	DAILY	C2-C5	Gabapentin, Naloxone, Butalbital, Promethazine in oral liquid formulations, Therapeutic Marijuana requests	No	No	Yes	Yes	www.pharmacy.la.gov	https://www.pharmacy.la.gov/assets/docs/PMP/Support_Guides/LA-Data-Submission-Dispenser-Guide_v3.2_2024.03.pdf
Maine	ME	4.2A	Bamboo	DAILY	Quarterly	C2-C5	NONE	No	No	Yes	Yes	https://www.maine.gov/dhhs/obh/providers/prescription-drug-monitoring-program	https://www.maine.gov/dhhs/sites/maine.gov.dhhs/files/inline-files/ME%20Data%20Submission%20Dispenser%20Guide_v3.3.docx
Maryland	MD	5	RXGov/Leap Orbit	DAILY	DAILY	ALL MEDS CONTROLS AND NON-CONTROLS - Beginning Sept 1, 2025	All drugs are reported	No	No	Yes	Yes	https://health.maryland.gov/pdmp/pages/home.aspx	https://health.maryland.gov/pdmp/Documents/[UPDATED]%20RxGov%20Data%20Submitter%20Guides/Maryland%20PDMP%20RxGov%20Data%20Submitter%20(v5.0)%20-%20August%202025.pdf
Massachusetts	MA	4.2A	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	Yes	Yes	No	https://www.mass.gov/orgs/prescription-monitoring-program	No URL found
Michigan	MI	5	Bamboo	DAILY	Optional	C2-C5	NONE	No	Yes	Yes	No	https://www.michigan.gov/lara/bureau-list/bpl/health/maps	https://www.michigan.gov/lara/-/media/Project/Websites/lara/bpl/MAPS/MI-Data-Submission-Dispenser-Guide_v51_AIR-corrected_12926.pdf?rev=8850ee12c07b4c19802216cc78d9cf16&hash=E559639EC7FF9E122592F57CC5CCE2B6
Minnesota	MN	4.2	Bamboo	DAILY	DAILY	C2-C5	BUTALBITAL, GABAPENTIN	No	No	Yes	No	https://mn.gov/boards/pharmacy-pmp/	https://mn.gov/boards/assets/MN%20Data%20Submission%20Dispenser%20Guide_v3.0_tcm21-563922.pdf#False
Mississippi	MS	4.2B	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	No	Yes	Yes	https://pmp.mbp.ms.gov/	https://pmp.mbp.ms.gov/sites/default/files/MS%20PMP%20Data%20Submission%20Dispenser%20Guide_v4.0.pdf
Missouri	MO	4.2	Bamboo	Real-time	Optional	C2-C4	NONE	No	No	No - only if a patient has MO HealthNet as a primary or secondary payer (Opioid treatment program)	No - only if a patient has MO HealthNet as a primary or secondary payer (Opioid treatment program)	https://pdmp.mo.gov/faq/	https://pdmp.mo.gov/wp-content/uploads/2025/09/mo-data-submission-dispenser-guide.pdf
Montana	MT	4.2A	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	No	No	No	https://boards.bsd.dli.mt.gov/pharmacy/mpdr/	https://boards.bsd.dli.mt.gov/_docs/pha/MT-Data-Submission-Dispenser-Guide.pdf
Nebraska	NE	5	CyncHealth	DAILY	DAILY	ALL MEDS CONTROLS AND NON-CONTROLS	N/A - All meds	No	Yes	Yes - for Medicaid patients only	No	https://dhhs.ne.gov/Pages/PDMP-Enhancements.aspx	https://dhhs.ne.gov/DOP%20document%20library/PDMP-Submitter-User-Guide.pdf
Nevada	NV	5	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://bop.nv.gov/links/pmp/	https://bop.nv.gov/uploadedFiles/bopnvgov/content/Links/NV%20Data%20Submission%20Dispenser%20Guide_v4.1.pdf
New Hampshire	NH	4.2B	Bamboo	DAILY	DAILY	C2-C4	NONE	No	Yes	Yes	No	https://www.dhhs.nh.gov/programs-services/population-health/prescription-drug-monitoring-program	https://www.dhhs.nh.gov/sites/g/files/ehbemt476/files/documents2/pdmp-guide-dispensers-3-1.pdf
New Jersey	NJ	4.2	Bamboo	DAILY	DAILY	C2-C5	Human Growth Hormone, Gabapentin	No	No	Yes	Yes	https://www.njconsumeraffairs.gov/dcu/Pages/applications.aspx	https://www.njconsumeraffairs.gov/pmp/Documents/NJPMP-Data-Submission-Dispenser-Guide.pdf
New Mexico	NM	4.2	Bamboo	DAILY	DAILY	C2-C5	Gabapentin (except when dispensed by a Vet)	No	No	Yes	Yes - Pharmacist Clinicians	https://www.nmpmp.info/	https://www.nmpmp.info/wp-content/uploads/2023/11/NM-PMP-Data-Submission-Dispenser-Guide_v4.0.pdf
New York	NY	4.2, 4.2A, 4.2B	In-House	DAILY	DAILY	C2-C5		No	Yes	Yes (Vets and in-house dispenses are exempt)	Optional	https://www.health.ny.gov/professionals/narcotic/prescription_monitoring/	https://www.health.ny.gov/professionals/narcotic/electronic_data_transmission/docs/submitter_guide.pdf
North Carolina	NC	4.2	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	Yes	Yes (Except when prescription period is 5 days or less)	No	https://www.ncdhhs.gov/divisions/mental-health-developmental-disabilities-and-substance-use-services/north-carolina-drug-control-unit/nc-controlled-substances-reporting-system	https://www.ncdhhs.gov/nc-data-submission-dispenser-guidev40/open
North Dakota	ND	4.2	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	Yes	Not required before prescribing. Annual PDMP review required only for patients on chronic opioid therapy (Board of Medicine rule).	Yes	https://www.nodakpharmacy.com/pdfs/AWARxEmanual.pdf	https://www.nodakpharmacy.com/pdfs/AWARxEmanual.pdf
Ohio	OH	5	Bamboo	DAILY	DAILY	C2-C5	Gabapentin, Naltrexone (only if prescribed for alcohol dependence or opioid relapse prevention), and any drug, whether scheduled or not, that is involved in a non-fatal overdose	No	Yes	Yes	Yes	https://ohiopmp.gov/	https://www.pharmacy.ohio.gov/documents/oarrs/general/pharmacies_prescribers/oarrs%20data%20submission%20guide%20for%20dispensers%20asap%205.0%20implementation%20-%20updated%204-30-26.pdf
Oklahoma	OK	4.2B	Bamboo	Real-time	Optional	C2-C5		Yes	Yes	Yes	Yes	https://www.obndd.ok.gov/registration-pmp/pmp#:~:text=All%20controlled%20substances%20dispensed%20in,carisoprodol%20and%20every%20180%20days.	https://www.obndd.ok.gov/home/showpublisheddocument/813/638950814628400000
Oregon	OR	4.2A	Bamboo	Within 72 hours	DAILY	C2-C5	Gabapentin	No	No	No	No	https://www.oregon.gov/oha/ph/preventionwellness/safeliving/pdmp/pages/index.aspx	https://www.oregon.gov/oha/PH/PREVENTIONWELLNESS/SAFELIVING/PDMP/Documents/Oregon_PDMP_Data_Submission_Dispenser_Guide.pdf
Pennsylvania	PA	4.2	Logicoy	DAILY	DAILY	C2-C5	Butalbital/Caffeine/Acetaminophen (Fioricet)	No	No	Yes	Yes	https://www.health.pa.gov/topics/programs/PDMP/Pages/Dispensers.aspx	https://pdmp.health.pa.gov/PDMPSystemApp/guidebeforelogin#!#documents
Rhode Island	RI	4.2A	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	No	https://health.ri.gov/healthcare/medicine/about/prescriptiondrugmonitoringprogram/	https://health.ri.gov/publications/guides/DataSubmissionDispenserGuideRIPDMP.pdf
South Carolina	SC	4.2B	Bamboo	DAILY	DAILY	C2-C4	NONE	No	Yes	Yes	No	https://scdhec.gov/healthcare-quality/drug-control-register-verify/prescription-monitoring	https://dph.sc.gov/sites/scdph/files/2025-06/SC_PMP_Data_Submission_Dispenser_Guide_v4.0.pdf
South Dakota	SD	4.2	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	No	No	https://doh.sd.gov/licensing-and-records/boards/pharmacy/prescription-drug-monitoring-program/	https://doh.sd.gov/media/qt1kphkb/pmp-awarxe_data-submission_guide-for-dispensers.pdf
Tennessee	TN	4.2A	Bamboo	DAILY	DAILY	C2-C5	Gabapentin (schedule V in TN), Butalbital (schedule III in TN),	Yes	Yes	Yes	Yes	https://www.tn.gov/health/health-program-areas/health-professional-boards/csmd-board.html	https://www.tn.gov/content/dam/tn/health/healthprofboards/csmd/TNDataCollectionManualTN.pdf
Texas	TX	4.2B	Bamboo	DAILY	DAILY	C2-C5	NONE	No	No	Yes	Yes	https://www.pharmacy.texas.gov/PMP/	https://www.pharmacy.texas.gov/files_pdf/pmp/data-submission-guide-for-dispensers.pdf
Utah	UT	5	In-House	DAILY	DAILY	C2-C5	Gabapentin, Butalbitol-containing products	No	No	Yes	Yes	https://www.dopl.utah.gov/controlled-substance-database/	http://2026commerce.utah.gov/wp-content/uploads/2025/09/U-PUP-Submitter-User-Guide.pdf
Vermont	VT	4.2B	Bamboo	DAILY	DAILY	C2-C4	NONE	No	No	Yes	No	https://www.healthvermont.gov/stats/registries/vermont-prescription-monitoring-system-vpms	https://www.healthvermont.gov/sites/default/files/documents/pdf/ADAP-VPMS-Data-Submission-Dispenser-Guide.pdf
Virginia	VA	4.2A	Bamboo	DAILY	DAILY	C2-C5	Gabapentin	No	Yes	Yes	Yes	https://www.dhp.virginia.gov/PractitionerResources/PrescriptionMonitoringProgram/PublicResources/WhatisthePMP/	https://www.dhp.virginia.gov/media/dhpweb/docs/pmp/VAPMPDispenserGuide_v3.0.pdf
Washington	WA	4.2A	Bamboo	DAILY	DAILY	C2-C5		No	Yes	Yes	Yes	https://www.doh.wa.gov/ForPublicHealthandHealthcareProviders/HealthcareProfessionsandFacilities/PrescriptionMonitoringProgramPMP	https://doh.wa.gov/sites/default/files/legacy/Documents/2600/WA-DataSubmissionDispenserGuide.pdf
Washington DC	DC	4.2A	Bamboo	DAILY	DAILY	C2-C5	Butalbital, Cyclobenzaprine, Gabapentin	No	Yes	Yes	Yes	https://dchealth.dc.gov/service/prescription-drug-monitoring-program	No URL found
West Virginia	WV	4.2	RXGov/Leap Orbit	DAILY	DAILY	C2-C5	GABAPENTIN, NALOXONE	No	Yes	Yes	No	https://www.csappwv.com/Account/Login.aspx?ReturnUrl=%2f	https://www.nascsa.org/documents/dispenserGuides/WestVirginia-V42.pdf
Wisconsin	WI	4.2B	In-House	DAILY	DAILY	C2-C5	Gabapentin	No	Yes	Yes	No	https://pdmp.wi.gov/	https://pdmp.wi.gov/Content/WIPDMPDataSubmitterGuide.pdf
Wyoming	WY	4.2	Bamboo	DAILY	7 days/Weekly	C2-C5	NALOXONE, Cyclobenzaprine, GABAPENTIN	No	No	Yes	No	https://pharmacyboard.wyo.gov/pdmp	https://drive.google.com/file/d/1LRP1Yg6GWNBP1VQj9jloHJVNXLq2NHDe/view
Northern Mariana Islands	CNMI	4.2A	In-House	DAILY	DAILY	ALL MEDS CONTROLS AND NON-CONTROLS	NONE				Yes	https://pdmp.chcc.health/home
Puerto Rico	PR	4.2	Bamboo	48 hours	DAILY	C2-C5	None					https://www.assmca.pr.gov/proyectos-especiales
State	Abbr		Vendor						Vet Reporting	Prescriber Mandatory Use	Pharmacy Mandatory Use

PMP News and Announcements

Stay informed with the latest announcements and developments related to Prescription Monitoring Programs (PMPs). Here, you’ll find articles and updates covering important changes, industry news, and insights to help you stay current on PMP-related topics.

The Department of Veterans Affairs (VA) proposes to amend its regulation that governs disclosure of information to and querying of State prescription drug monitoring programs (PDMPs)

Jun 5, 2026 | News, PMP

May 20, 2026 - The Department of Veterans Affairs published a proposed rule in the Federal Register (Document Citation 91 FR 29407 [federalregister.gov]). The Summary Reads, “The Department of Veterans Affairs (VA) proposes to amend its regulation that governs...

Free Continuing Education for Pharmacists/Technicians on Improving Prescription Monitoring Program (PMP) Data

Oct 27, 2025 | PMP, Uncategorized

Take advantage of this free ACPE accredited educational opportunity providing one (1) hour of continuing education (CE) for pharmacists and pharmacy technicians. This program, developed in partnership with NASCSA and 12 prescription monitoring program (PMP)...

Available Webinar – ASAP Through the Years: A Journey to Version 5.0

Sep 25, 2025 | PMP

Available Webinar - ASAP Through the Years: A Journey to Version 5.0 featuring speaker Kevin Borcher, PharmD, Senior PDMP Specialist, PDMP TTAC Institute for Intergovernmental Research (IIR). The YouTube video is available here.

« Older Entries

PMP Spotlights

This section features recent PMP press releases. The intent is to highlight a few programs at a time and is not meant to be a comprehensive list of all the PMPs in the news. If you would like to suggest a particular state / jurisdiction’s recent PMP press release, please contact us.

Delaware

6/24/20: The Delaware Office of Controlled Substances (OCS) is pleased to announce a partnership with Appriss Health to provide interoperability services for all prescribers and pharmacists in Delaware. This service will enable providers to quickly and efficiently access PMP Aware and Narxcare data within their EHR, EMR, or pharmacy dispensing software through the PDMP Gateway® while minimizing interruptions to workflow and patient care. The project is funded by a grant from the Centers for Disease Control awarded to the Delaware Division of Public Health. Click here to read the press release.

Illinois

8/23/21: Amid rising opioid overdose rates, State Senator Mattie Hunter (D-Chicago) proposes a new law to increase regulations for the prescription monitoring program (PMP). Senate Bill 1842 allows the PMP to send automatic reports to prescribers and dispensers when medication shopping is detected from five identifications of a prescriber or pharmacy in a six month period. Click here to read the press release.

Missouri

6/7/21: Governor Parson signs SB 63: Creating Statewide Prescription Drug Monitoring Program in Missouri. Click here to read the press release.
10/20/20: Saint Louis County PDMP Enables Additional Enhancements for Heathcare Providers. The PDMP monitors the prescribing and dispensing of schedule II-IV controlled substances to assist in the identification and prevention of prescription drug misuse. The goals of this program are to improve controlled substance prescribing, inform clinical practice, and reduce medication misuse and overdose. The system sends Clinical Alerts to assist healthcare providers in identifying patients potentially at risk for overdose or addiction (substance use disorders). Click here to read the press release.

New Jersey

8/31/20: The New Jersey Prescription Monitoring Program (NJPMP), in partnership with the New Jersey Department of Human Services, announces $1.2 Million in funding obtained from the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) to implement NJPMP integration with electronic health records and pharmacy management systems across the state. Click here to read the press release.

Additional PMP Resources

American Association of Automation in Pharmacy

U.S. Drug Enforcement Administration, Office of Diversion Control

CDC’s Response to the Opioid Epidemic

U.S. Department of Justice

Bureau of Justice Assistance (BJA)

Grants.gov

National Association of Boards of Pharmacy (NABP) PMP InterConnect

National Council for Prescription Drug Programs (NCPDP)

NASCSA Data Integrity Guide for PMP Administrators

2024 NASCSA Model PMP Act

PDMP Training and Technical Assistance Center (TTAC)

PDMPWorks

PMIX

RxCheck

Substance Abuse and Mental Health Services Administration (SAMSHA)

Stay in the Loop on PMP Updates!

Sign up to receive direct communication from state administrators regarding important updates to Prescription Monitoring Program (PMP) requirements. By joining this list, you’ll ensure that your company or organization stays informed about critical changes, helping you remain compliant and ahead of the curve.

Please note: By submitting your contact information, you agree to receive communication via email directly from state administrators, not NASCSA.